Differential Cytotoxicity of PVP-Copper Nanoparticles in Breast Cancer Cell Lines: Insights from Basal Transcriptomic Profiles
Preprint
Abstract
Breast cancer is a heterogeneous disease comprising molecular subtypes with distinct therapeutic vulnerabilities. Among emerging therapeutic strategies, copper-based nanoparticles have shown anticancer activity. However, whether these responses differ across breast cancer subtypes and which molecular programs underlie copper sensitivity remain poorly understood. We investigated subtype-specific responses to Polyvinylpyrrolidone-assisted copper nanoparticles (CuNP-PVP) in breast cancer cell lines and the molecular programs underlying copper adaptation. CuNP-PVP were synthesized and evaluated in luminal (MCF-7), HER2-positive (SKBR3), and triple-negative (MDA-MB-231) breast cancer cell lines, with transcriptomic analyses integrated with CCLE and TCGA-BRCA datasets. UV-Vis spectroscopy revealed a plasmon resonance band at 591 nm, while TEM showed spherical nanoparticles with an average diameter of 76.1 ± 21.0 nm. DLS indicated a larger hydrodynamic diameter, consistent with PVP coating; ζ-potential measurements showed a surface charge of −13 mV, and XPS confirmed mixed reduced and Cu(I)/Cu(II) oxidation states. Exposure to 100 μg/mL CuNP-PVP induced subtype-dependent effects on cell viability, with MCF-7 showing greater sensitivity, whereas MDA-MB-231 and SKBR3 were less affected. Baseline transcriptomic analyses revealed enrichment of oxidative stress, metabolic adaptation, and lysosomal programs in less sensitive cells, whereas MCF-7 showed higher expression of lipoylation-related genes. These features supported the development of a Potential Biological Copper-Response Index (PBCRI), which captured subtype-associated transcriptional patterns across independent cell lines and patient tumors, with luminal models showing lower scores and basal/TNBC models showing higher scores. Together, these findings identify candidate transcriptional programs associated with subtype-specific responses to CuNP and provide a framework for investigating potential molecular determinants of copper sensitivity. Highlights: PVP-assisted copper nanoparticles showed mixed metallic/oxidized Cu phases. CuNP-PVP induced cell-dependent cytotoxicity in breast cancer cells. MCF-7 cells were more sensitive to CuNP-PVP than TNBC and HER2+ cells. Baseline profiles differed in lipoylation, antioxidant, and lysosomal programs. PBCRI captured subtype-associated copper-response transcriptional patterns.Keywords
This publication has 55 references indexed in Scilit:
- Metabolic underpinnings of cuproptosisCell Chemical Biology, 2026
- Copper nanoparticles: synthesis, stabilization, and antimicrobial screeningJournal of Nanoparticle Research, 2026
- Enhanced Antibiofilm Activity of Copper Nanoparticles Stabilized With Polyvinyl Pyrrolidone and Polyvinyl Alcohol Against Pseudomonas aeruginosa and Staphylococcus aureusJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2025
- Copper-based nanoplatforms and their role in cancer therapyCoordination Chemistry Reviews, 2025
- Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunitiesCancer Communications, 2025
- Nanotechnology connecting copper metabolism and tumor therapyMedcomm – Biomaterials and Applications, 2023
- Current and future burden of breast cancer: Global statistics for 2020 and 2040The Breast, 2022
- Anti-oxidative copper nanoparticle paste for Cu–Cu bonding at low temperature in airJournal of Materials Science: Materials in Electronics, 2021
- ROS-induced cytotoxicity of colloidal copper nanoparticles in MCF-7 human breast cancer cell line: an in vitro studyJournal of Nanoparticle Research, 2020
- Copper: toxicological relevance and mechanismsArchives of Toxicology, 2014